AC
TXG icon

Allstate Corporation’s 10x Genomics TXG Stock Holding History

Allstate Corporation’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$267K Buy
+6,963
New +$182K ﹤0.01% 1233
2021
Q4 		– Sell
-1,717
Closed -$250K – 764
2021
Q3 		$250K Buy
1,717
+555
+48% +$95.3K 0.01% 663
2021
Q2 		$228K Buy
+1,162
New +$210K 0.01% 694

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Allstate Corporation's TXG Position: Q2 2026 in Review

Allstate Corporation opened a new position in 10x Genomics (TXG) in Q2 2026: 6,963 shares worth $267K. The stake represents ﹤0.01% of the portfolio and ranks #1233 among its holdings. This is a return to the name: Allstate Corporation previously reported a position in TXG as recently as Q3 2021.

Allstate Corporation first reported a position in TXG in Q2 2021 and has held it in 3 quarters since. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Allstate Corporation held 6,963 shares of 10x Genomics worth $267K as of Q2 2026.
  • 10x Genomics was a new Allstate Corporation position in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Allstate Corporation's portfolio in Q2 2026, its #1233 holding.
  • Allstate Corporation first reported a position in 10x Genomics in Q2 2021 and has held it in 3 quarters since.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.